Table 1. Patient characteristics N (%) and hazard ratios (HR) together with 95%-confidence intervals (CI) for factors.
| Factor | Model 1: HR (CI) | Model 2: HR (CI) | |||
| Dialysis modality1 | HD | PD | All | ||
| 8273 (68) | 3822 (32) | 12095 (100) | .89 (.84–.93) | .87 (.83–.92)** | |
| Cohort | ** | ** | |||
| 1990–94 | 1099 (13) | 748 (20) | 1847 (15) | 1 (ref) | 1 (ref) |
| 1995–99 | 1877 (23) | 792 (21) | 2669 (22) | .85 (.79–.91)** | .86 (.80–.93)* |
| 2000–04 | 2482 (30) | 1022 (27) | 3504 (29) | .7 (.65–.75)** | .76 (.70–.81)** |
| 2005–10 | 2815 (34) | 1260 (33) | 4075 (34) | .59 (.54–.64)** | .66 (.61–.72)** |
| Age | ** | ||||
| 0–59 | 2961 (36) | 1962 (51) | 4923 (41) | 1 (ref) | |
| 60–69 | 2158 (26) | 975 (26) | 3133 (26) | 1.88 (1.76–2.01)** | |
| 70–79 | 2337 (28) | 697 (18) | 3034 (25) | 2.7 (2.52–2.89)** | |
| > = 80 | 817 (10) | 188 (5) | 1005 (8) | 3.62 (3.3–3.97)** | |
| Age> = 65 | 4335 (52) | 1344 (35) | 5679 (47) | 2.09 (1.99–2.20)** | |
| Female Sex | 3045 (37) | 1449 (38) | 4494 (37) | .98 (.94–1.03) | .99 (.94–1.04) |
| Renal Diagnosis | ** | ||||
| Unknown | 1931 (23) | 852 (22) | 2783 (23) | 1 (ref) | |
| Glomerulonephritis (GN) | 846 (10) | 590 (15) | 1436 (12) | .76 (.69–.84)** | |
| Chronic interstitial (CIN) | 996 (12) | 390 (10) | 1386 (12) | .92 (.85–1) | |
| Polycystic | 504 (6) | 356 (9) | 860 (7) | .73 (.66–.82)** | |
| Hypertensive | 961 (12) | 430 (11) | 1391 (11) | .99 (.91–1.07) | |
| Type 1 DM | 824 (10) | 632 (17) | 1456 (12) | 1.57 (1.44–1.71)** | |
| Type 2 DM | 998 (12) | 284 (7) | 1282 (11) | 1.41 (1.30–1.52)** | |
| Renal Cancer | 136 (2) | 19 (0.5) | 155 (1) | 1.13 (.90–1.42) | |
| Myeloma | 207 (3) | 32 (0.8) | 239 (2) | 2.08 (1.75–2.47)** | |
| Amyloidosis | 71 (0.9) | 41 (1) | 112 (0.9) | 2.11 (1.64–2.73)** | |
| Systemic GN | 97 (1) | 52 (1) | 149 (1) | .98 (.76–1.26) | |
| Vasculitis | 377 (5) | 70 (2) | 447 (4) | .83 (.72–.96)* | |
| HUS/TTP2 | 40 (0.5) | 15 (0.4) | 55 (0.5) | .49 (.29–.81)* | |
| Other | 285 (3) | 59 (2) | 344 (3) | .97 (.83–1.13) | |
| DM diagnosis | 1822 (22) | 916 (24) | 2738 (23) | 1.51 (1.43–1.6)** | |
| Comorbidity | ** | ** | |||
| 0 | 2837 (34) | 1941 (51) | 4778 (40) | 1 (ref) | 1 (ref) |
| 1–2 | 3623 (44) | 1423 (37) | 5046 (42) | 1.6 (1.51–1.69)** | 1.69 (1.6–1.79)** |
| >2 | 1813 (22) | 458 (12) | 2271 (19) | 2.3 (2.14–2.46)** | 2.52 (2.35–2.7)** |
| ESRD Initiation | ** | ** | |||
| Early & Routine | 2145 (26) | 1419 (37) | 3564 (29) | .91 (.86–.96)* | .89 (.84–.94)** |
| Late & Acute | 2138 (26) | 648 (17) | 2786 (23) | 1.1 (1.03–1.16)* | 1.12 (1.05–1.19)** |
| Other | 3990 (48) | 1755 (46) | 5745 (47) | 1 (ref) | 1 (ref) |
Corresponding significant p-values are presented as.
*: p<.05;
**:p<.001.
For definition of models see methods section.
1
:HD is the reference category;
2
: Hemolytic Uremic Syndrome/ThrombocoticThrombocytopenic Purpura.